Cyclin Dependent Kinase Inhibitor 2B (CDKN2B) Antibody

This gene lies adjacent to the tumor suppressor gene CDKN2A in a region that is frequently mutated and deleted in a wide variety of tumors. This gene encodes a cyclin-dependent kinase inhibitor, which forms a complex with CDK4 or CDK6, and prevents the activation of the CDK kinases, thus the encoded protein functions as a cell growth regulator that controls cell cycle G1 progression. The expression of this gene was found to be dramatically induced by TGF beta, which suggested its role in the TGF beta induced growth inhibition. Two alternatively spliced transcript variants of this gene, which encode distinct proteins, have been reported.

Target	Cyclin Dependent Kinase Inhibitor 2B (CDKN2B)
Clonality	Polyclonal
Reactivity	Human
Tested Applications	ELISA, WB, IHC, IF/ICC, FCM
Host	Rabbit
Recommended dilutions	WB: 1/1000, IHC-P: 1/10 - 1/50, IF/ICC: 1/10 - 1/50, FCM: 1/10 - 1/50. Not tested in IHC-F. Optimal dilutions/concentrations should be determined by the end user.
Conjugation	Unconjugated
Immunogen	KLH-conjugated synthetic peptide between 102-130 amino acids from the C-terminal region of human CDKN2B.
Isotype	IgG
Form	Liquid
Purification	Purified through a protein A column, followed by peptide affinity purification.
Storage	Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
UniProt Primary AC	P42772 (UniProt, ExPASy)
UniProt Secondary AC	O15125, Q6FI09
UniProt Entry Name	CDN2B_HUMAN
Gene Symbol	CDKN2B
KEGG	hsa:1030
String	9606.ENSP00000276925
Molecular Weight	Calculated MW: 14.7 kDa
Buffer	PBS containing 0.09% sodium azide.
Availability	Shipped within 5-10 working days.
Note	This product is for research use only.

Research Articles on Cyclin Dependent Kinase Inhibitor 2B (CDKN2B)

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue